Summary
This 8-K filing by Altria Group, Inc. (MO) on December 7, 2018, announces a significant strategic investment in Cronos Group Inc., a Canadian cannabis company. Altria, through its subsidiary Altria Summit LLC, is acquiring approximately 45% of Cronos's outstanding shares for $1.8 billion, with an option to increase its stake to approximately 55% upon exercising a warrant. This move marks Altria's entry into the rapidly growing cannabis market, diversifying its business beyond traditional tobacco products. The investment comes with significant governance rights for Altria, including the right to nominate a substantial portion of Cronos's board of directors, as long as its ownership remains above certain thresholds. The company also outlines the financing for this transaction, which includes a CAD$2.4 billion bridge loan facility. The closing of the transaction is subject to customary conditions, including shareholder and regulatory approvals.
Key Highlights
- 1Altria is investing approximately $1.8 billion to acquire a 45% stake in Cronos Group Inc., a Canadian cannabis company.
- 2The investment includes a warrant that could allow Altria to increase its ownership to approximately 55% of Cronos.
- 3This strategic move signifies Altria's diversification into the burgeoning cannabis industry.
- 4Altria will gain significant influence over Cronos's governance, with the right to nominate a majority of the board of directors under certain ownership levels.
- 5The transaction is financed by a CAD$2.4 billion bridge loan facility provided by JPMorgan Chase Bank, N.A.
- 6Closing of the transaction is contingent upon customary conditions, including Cronos shareholder approval and regulatory clearances.